Boris Jordan & Curaleaf

Boris Jordan: Boris Jordan>>>, Chairman and CEO of Curaleaf>>>, views the reverse stock split as a crucial step in the company's long-term strategy to uplist to a major U.S. stock exchange, anticipating regulatory changes in the cannabis industry.

Curaleaf: Curaleaf>>> is implementing a reverse stock split to increase its share price, aiming to meet listing criteria for major U.S. stock exchanges and attract institutional investors. This move is expected to improve its market positioning and access to capital.

Boris Jordan: Boris Jordan, Chairman and CEO of Curaleaf, commented on the return to the CURLF trading symbol, emphasizing the company's focus on strengthening its capital markets profile and positioning for future opportunities.

Curaleaf: Curaleaf's shares resumed trading under its original OTCQX symbol CURLF after a temporary transition period following a reverse stock split, providing continuity for investors and potentially strengthening its capital markets profile.

Boris Jordan: As Chairman and CEO, Boris Jordan commented on the listing, highlighting its significance for Curaleaf's market maturity.

Curaleaf: Curaleaf is the subject of the event; the options listing enhances its market maturity and provides investors with new hedging and income strategies, potentially increasing liquidity and institutional interest.

Boris Jordan: As CEO and Chairman of Curaleaf, Boris Jordan announced the registration milestone, highlighting the company's long-term investment in Spain and its commitment to providing standardized cannabis medicines.

Curaleaf: Curaleaf secured the first registration of standardized cannabis preparations in Spain under the new Royal Decree 903/2025, strengthening its leadership in the European medicinal cannabis market and potentially increasing its market share and revenue.